We are live on ! Find out more
ECP

Empyrean Capital Partners Portfolio holdings

AUM $3.07B
1-Year Est. Return 34.24%
This Fund
S&P 500
This Quarter Est. Return
+18.67%
1 Year Est. Return
+34.24%
3 Year Est. Return
+104.05%
5 Year Est. Return
+133.06%
10 Year Est. Return
+500.1%
AUM
$3.16B
AUM Growth
+$1.29B
Cap. Flow
+$905M
Cap. Flow %
28.69%
Top 10 Hldgs %
54.05%
Holding
89
New
25
Increased
13
Reduced
14
Closed
10

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$135M
2
SHPG
Shire pic
SHPG
+$82.3M
3
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$79.1M
4
EQH icon
Equitable Holdings
EQH
+$61.8M
5
GSAH.U
GS Acquisition Holdings Corp. Units, each consisting of one share of Class A common stock and one-th
GSAH.U
+$35.8M

Top Sells

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$182M
2
HRG
HRG Group, Inc.
HRG
+$92.4M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$84.7M
4
PFE icon
Pfizer
PFE
+$33.3M
5
XRX icon
Xerox
XRX
+$28.6M

Sector Composition

Rank Sector Weight
1 Financials 14.66%
2 Technology 8.15%
3 Communication Services 7.48%
4 Healthcare 6.5%
5 Real Estate 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRG
76
DELISTED
HRG Group, Inc.
HRG
– –
-5,602,112
Closed -$92.4M
1 2 3
4

Similar funds

MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
DCM
Donaldson Capital Management Evansville, Indiana $3.09B AUM 21.24% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.05B AUM 12.73% 1-Year Est. Return

Empyrean Capital Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Empyrean Capital Partners held 89 positions worth $3.16B, up 69% from $1.87B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Empyrean Capital Partners deployed $905M of net new capital in Q2 2018, opening 25 new positions and adding to 13 existing holdings. Its largest new stake was Aetna Inc: 759,600 shares worth $139M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 11% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Pfizer, an estimated $33.3M trimmed.

  • Empyrean Capital Partners's largest Q2 2018 buy was Aetna Inc: 759,600 shares worth $139M.
  • Empyrean Capital Partners added most to NXP Semiconductors in Q2 2018, an estimated $31.1M increase.
  • Empyrean Capital Partners's biggest Q2 2018 reduction was Pfizer, cutting an estimated $33.3M.
  • Empyrean Capital Partners fully exited Time Warner Inc in Q2 2018, selling an estimated $182M.
  • Empyrean Capital Partners's ten largest holdings make up 54% of its $3.16B portfolio in Q2 2018.
  • Empyrean Capital Partners opened 25 new positions and closed 10 in Q2 2018.
  • Empyrean Capital Partners's portfolio value rose 69% quarter-over-quarter to $3.16B.

Based on Empyrean Capital Partners's 13F filing for Q2 2018, filed 14 Aug 2018.